{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:14:20Z","timestamp":1780492460105,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Luminesce Alliance"},{"name":"The Children\u2019s Hospital at Westmead Volunteer\u2019s Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20005-w","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:59:38Z","timestamp":1760525978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the utility of growth differentiation factor 15 and fibroblast growth factor 21 as blood biomarkers for Rett syndrome"],"prefix":"10.1038","volume":"15","author":[{"given":"Ashley","family":"Hertzog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adviye Ayper","family":"Tolun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D.","family":"Wykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel N.","family":"Breit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Ellaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"20005_CR1","first-page":"723","volume":"116","author":"A Rett","year":"1966","unstructured":"Rett, A. On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med. Wochenschr. 116, 723\u2013726 (1966).","journal-title":"Wien Med. Wochenschr."},{"key":"20005_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1651-2227.1995.tb13809.x","volume":"84","author":"B Hagberg","year":"1995","unstructured":"Hagberg, B. Rett syndrome: clinical peculiarities and biological mysteries. Acta Paediatr. 84, 971\u2013976. https:\/\/doi.org\/10.1111\/j.1651-2227.1995.tb13809.x (1995).","journal-title":"Acta Paediatr."},{"key":"20005_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jpeds.2005.10.037","volume":"148","author":"CL Laurvick","year":"2006","unstructured":"Laurvick, C. L. et al. Rett syndrome in australia: a review of the epidemiology. J. Pediatr. 148, 347\u2013352. https:\/\/doi.org\/10.1016\/j.jpeds.2005.10.037 (2006).","journal-title":"J. Pediatr."},{"key":"20005_CR4","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","volume":"70","author":"JL Neul","year":"2008","unstructured":"Neul, J. L. et al. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 70, 1313\u20131321. https:\/\/doi.org\/10.1212\/01.wnl.0000291011.54508.aa (2008).","journal-title":"Neurology"},{"key":"20005_CR5","doi-asserted-by":"publisher","first-page":"1172805","DOI":"10.3389\/fnins.2023.1172805","volume":"17","author":"M Palmieri","year":"2023","unstructured":"Palmieri, M., Pozzer, D. & Landsberger, N. Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives. Front. Neurosci. 17, 1172805. https:\/\/doi.org\/10.3389\/fnins.2023.1172805 (2023).","journal-title":"Front. Neurosci."},{"key":"20005_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fnint.2020.00007","volume":"14","author":"JL Neul","year":"2020","unstructured":"Neul, J. L. et al. Metabolic signatures differentiate Rett syndrome from unaffected siblings. Front. Integr. Neurosci. 14, 7. https:\/\/doi.org\/10.3389\/fnint.2020.00007 (2020).","journal-title":"Front. Integr. Neurosci."},{"key":"20005_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmg.2004.027730","volume":"42","author":"LS Weaving","year":"2005","unstructured":"Weaving, L. S., Ellaway, C. J., Gecz, J. & Christodoulou, J. Rett syndrome: clinical review and genetic update. J. Med. Genet. 42, 1\u20137. https:\/\/doi.org\/10.1136\/jmg.2004.027730 (2005).","journal-title":"J. Med. Genet."},{"key":"20005_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/hmg\/11.2.115","volume":"11","author":"MD Shahbazian","year":"2002","unstructured":"Shahbazian, M. D., Antalffy, B., Armstrong, D. L. & Zoghbi, H. Y. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11, 115\u2013124. https:\/\/doi.org\/10.1093\/hmg\/11.2.115 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"20005_CR9","doi-asserted-by":"publisher","unstructured":"Gulmez Karaca, K., Brito, D. V. C. & Oliveira, A. M. M. MeCP2: a critical regulator of chromatin in neurodevelopment and adult brain function. Int. J. Mol. Sci. 20 https:\/\/doi.org\/10.3390\/ijms20184577 (2019).","DOI":"10.3390\/ijms20184577"},{"key":"20005_CR10","doi-asserted-by":"publisher","first-page":"e64863","DOI":"10.1371\/journal.pone.0064863","volume":"8","author":"A Panighini","year":"2013","unstructured":"Panighini, A. et al. Vascular dysfunction in a mouse model of Rett syndrome and effects of curcumin treatment. PLoS One 8, e64863. https:\/\/doi.org\/10.1371\/journal.pone.0064863 (2013).","journal-title":"PLoS One"},{"key":"20005_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/CH-131707","volume":"54","author":"G Bianciardi","year":"2013","unstructured":"Bianciardi, G. et al. Microvascular abnormalities in Rett syndrome. Clin. Hemorheol. Microcirc. 54, 109\u2013113. https:\/\/doi.org\/10.3233\/CH-131707 (2013).","journal-title":"Clin. Hemorheol. Microcirc"},{"key":"20005_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.12703\/r\/10-59","volume":"10","author":"E Borloz","year":"2021","unstructured":"Borloz, E., Villard, L. & Roux, J. C. Rett syndrome: think outside the (skull) box. Fac. Rev. 10, 59. https:\/\/doi.org\/10.12703\/r\/10-59 (2021).","journal-title":"Fac. Rev."},{"key":"20005_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0387-7604(93)90045-a","volume":"15","author":"MT Dotti","year":"1993","unstructured":"Dotti, M. T. et al. Mitochondrial dysfunction in Rett syndrome. An ultrastructural and biochemical study. Brain Dev. 15, 103\u2013106. https:\/\/doi.org\/10.1016\/0387-7604(93)90045-a (1993).","journal-title":"Brain Dev."},{"key":"20005_CR14","first-page":"301","volume":"31","author":"E Cardaioli","year":"1999","unstructured":"Cardaioli, E., Dotti, M. T., Hayek, G., Zappella, M. & Federico, A. Studies on mitochondrial pathogenesis of Rett syndrome: ultrastructural data from skin and muscle biopsies and mutational analysis at MtDNA nucleotides 10463 and 2835. J. Submicrosc. Cytol. Pathol. 31, 301\u2013304 (1999).","journal-title":"J. Submicrosc. Cytol. Pathol."},{"key":"20005_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0887-8994(90)90028-y","volume":"6","author":"S Wakai","year":"1990","unstructured":"Wakai, S. et al. Rett syndrome: findings suggesting axonopathy and mitochondrial abnormalities. Pediatr. Neurol. 6, 339\u2013343. https:\/\/doi.org\/10.1016\/0887-8994(90)90028-y (1990).","journal-title":"Pediatr. Neurol."},{"key":"20005_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/088307389400900419","volume":"9","author":"ME Cornford","year":"1994","unstructured":"Cornford, M. E., Philippart, M., Jacobs, B., Scheibel, A. B. & Vinters, H. V. Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain. J. Child. Neurol. 9, 424\u2013431. https:\/\/doi.org\/10.1177\/088307389400900419 (1994).","journal-title":"J. Child. Neurol."},{"key":"20005_CR17","doi-asserted-by":"publisher","unstructured":"Signorini, C. et al. Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome. Oxid. Med. Cell. Longev.  195935. https:\/\/doi.org\/10.1155\/2014\/195935 (2014).","DOI":"10.1155\/2014\/195935"},{"key":"20005_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2202-11-53","volume":"11","author":"JH Gibson","year":"2010","unstructured":"Gibson, J. H. et al. Downstream targets of Methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain. BMC Neurosci. 11, 53. https:\/\/doi.org\/10.1186\/1471-2202-11-53 (2010).","journal-title":"BMC Neurosci."},{"key":"20005_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mito.2014.02.012","volume":"15","author":"WA Gold","year":"2014","unstructured":"Gold, W. A. et al. Mitochondrial dysfunction in the skeletal muscle of a mouse model of Rett syndrome (RTT): implications for the disease phenotype. Mitochondrion 15, 10\u201317. https:\/\/doi.org\/10.1016\/j.mito.2014.02.012 (2014).","journal-title":"Mitochondrion"},{"key":"20005_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fncel.2017.00058","volume":"11","author":"N Shulyakova","year":"2017","unstructured":"Shulyakova, N., Andreazza, A. C., Mills, L. R. & Eubanks, J. H. Mitochondrial dysfunction in the pathogenesis of Rett syndrome: implications for mitochondria-targeted therapies. Front. Cell. Neurosci. 11, 58. https:\/\/doi.org\/10.3389\/fncel.2017.00058 (2017).","journal-title":"Front. Cell. Neurosci."},{"key":"20005_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cyto.2015.10.002","volume":"77","author":"A Pecorelli","year":"2016","unstructured":"Pecorelli, A. et al. Cytokines profile and peripheral blood mononuclear cells morphology in Rett and autistic patients. Cytokine 77, 180\u2013188. https:\/\/doi.org\/10.1016\/j.cyto.2015.10.002 (2016).","journal-title":"Cytokine"},{"key":"20005_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.freeradbiomed.2020.02.023","volume":"152","author":"A Pecorelli","year":"2020","unstructured":"Pecorelli, A., Cervellati, C., Cordone, V., Hayek, J. & Valacchi, G. Compromised immune\/inflammatory responses in Rett syndrome. Free Radic. Biol. Med. 152, 100\u2013106. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.023 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"20005_CR23","doi-asserted-by":"publisher","first-page":"108660","DOI":"10.1016\/j.abb.2020.108660","volume":"696","author":"V Cicaloni","year":"2020","unstructured":"Cicaloni, V. et al. A proteomics approach to further highlight the altered inflammatory condition in Rett syndrome. Arch. Biochem. Biophys. 696, 108660. https:\/\/doi.org\/10.1016\/j.abb.2020.108660 (2020).","journal-title":"Arch. Biochem. Biophys."},{"key":"20005_CR24","doi-asserted-by":"publisher","first-page":"10997","DOI":"10.1038\/s41598-021-90517-8","volume":"11","author":"MI Zalosnik","year":"2021","unstructured":"Zalosnik, M. I., Fabio, M. C., Bertoldi, M. L., Castanares, C. N. & Degano, A. L. MeCP2 deficiency exacerbates the neuroinflammatory setting and autoreactive response during an autoimmune challenge. Sci. Rep. 11, 10997. https:\/\/doi.org\/10.1038\/s41598-021-90517-8 (2021).","journal-title":"Sci. Rep."},{"key":"20005_CR25","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1194\/jlr.P017798","volume":"52","author":"C De Felice","year":"2011","unstructured":"De Felice, C. et al. F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome. J. Lipid Res. 52, 2287\u20132297. https:\/\/doi.org\/10.1194\/jlr.P017798 (2011).","journal-title":"J. Lipid Res."},{"key":"20005_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12263-012-0285-7","volume":"7","author":"C De Felice","year":"2012","unstructured":"De Felice, C. et al. Partial rescue of Rett syndrome by omega-3 polyunsaturated fatty acids (PUFAs) oil. Genes Nutr. 7, 447\u2013458. https:\/\/doi.org\/10.1007\/s12263-012-0285-7 (2012).","journal-title":"Genes Nutr."},{"key":"20005_CR27","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/acn3.51104","volume":"7","author":"Y Lin","year":"2020","unstructured":"Lin, Y. et al. Accuracy of FGF-21 and GDF-15 for the diagnosis of mitochondrial disorders: a meta-analysis. Ann. Clin. Transl. Neurol. 7, 1204\u20131213. https:\/\/doi.org\/10.1002\/acn3.51104 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"20005_CR28","doi-asserted-by":"publisher","first-page":"1264530","DOI":"10.3389\/fendo.2023.1264530","volume":"14","author":"J Jena","year":"2023","unstructured":"Jena, J., Garcia-Pena, L. M. & Pereira, R. O. The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response. Front. Endocrinol. (Lausanne). 14, 1264530. https:\/\/doi.org\/10.3389\/fendo.2023.1264530 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"20005_CR29","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1212\/WNL.0000000000002705","volume":"86","author":"RL Davis","year":"2016","unstructured":"Davis, R. L., Liang, C. & Sue, C. M. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases. Neurology 86, 2010\u20132015. https:\/\/doi.org\/10.1212\/WNL.0000000000002705 (2016).","journal-title":"Neurology"},{"key":"20005_CR30","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1212\/WNL.0000000000003374","volume":"87","author":"JM Lehtonen","year":"2016","unstructured":"Lehtonen, J. M. et al. FGF21 is a biomarker for mitochondrial translation and MtDNA maintenance disorders. Neurology 87, 2290. https:\/\/doi.org\/10.1212\/WNL.0000000000003374 (2016).","journal-title":"Neurology"},{"key":"20005_CR31","doi-asserted-by":"publisher","first-page":"e0148709","DOI":"10.1371\/journal.pone.0148709","volume":"11","author":"R Montero","year":"2016","unstructured":"Montero, R. et al. GDF-15 is elevated in children with mitochondrial diseases and is induced by mitochondrial dysfunction. PLoS One. 11, e0148709. https:\/\/doi.org\/10.1371\/journal.pone.0148709 (2016).","journal-title":"PLoS One"},{"key":"20005_CR32","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","volume":"10","author":"A Suomalainen","year":"2011","unstructured":"Suomalainen, A. et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 10, 806\u2013818. https:\/\/doi.org\/10.1016\/S1474-4422(11)70155-7 (2011).","journal-title":"Lancet Neurol."},{"key":"20005_CR33","doi-asserted-by":"publisher","unstructured":"Manoli, I. et al. FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia. JCI Insight 3 https:\/\/doi.org\/10.1172\/jci.insight.124351 (2018).","DOI":"10.1172\/jci.insight.124351"},{"key":"20005_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-physiol-022020-045449","volume":"83","author":"SN Breit","year":"2021","unstructured":"Breit, S. N., Brown, D. A. & Tsai, V. W. The GDF15-GFRAL pathway in health and metabolic disease: friend or foe?? Annu. Rev. Physiol. 83, 127\u2013151. https:\/\/doi.org\/10.1146\/annurev-physiol-022020-045449 (2021).","journal-title":"Annu. Rev. Physiol."},{"key":"20005_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell. Biol. 19, 121\u2013135. https:\/\/doi.org\/10.1038\/nrm.2017.95 (2018).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"20005_CR36","doi-asserted-by":"publisher","first-page":"110439","DOI":"10.1016\/j.biopha.2020.110439","volume":"129","author":"K Kang","year":"2020","unstructured":"Kang, K. et al. FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress. Biomed. Pharmacother. 129, 110439. https:\/\/doi.org\/10.1016\/j.biopha.2020.110439 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"20005_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","volume":"28","author":"VWW Tsai","year":"2018","unstructured":"Tsai, V. W. W., Husaini, Y., Sainsbury, A., Brown, D. A. & Breit, S. N. The MIC-1\/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases. Cell. Metab. 28, 353\u2013368. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.018 (2018).","journal-title":"Cell. Metab."},{"key":"20005_CR38","doi-asserted-by":"publisher","first-page":"1058665","DOI":"10.3389\/fnagi.2022.1058665","volume":"14","author":"A Chiariello","year":"2022","unstructured":"Chiariello, A. et al. The expression pattern of GDF15 in human brain changes during aging and in alzheimer\u2019s disease. Front. Aging Neurosci. 14, 1058665. https:\/\/doi.org\/10.3389\/fnagi.2022.1058665 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"20005_CR39","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3892\/etm.2021.10705","volume":"22","author":"WW Jiang","year":"2021","unstructured":"Jiang, W. W. et al. Emerging roles of growth differentiation factor-15 in brain disorders (Review). Exp. Ther. Med. 22, 1270. https:\/\/doi.org\/10.3892\/etm.2021.10705 (2021).","journal-title":"Exp. Ther. Med."},{"key":"20005_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nn.2997","volume":"15","author":"D Goffin","year":"2011","unstructured":"Goffin, D. et al. Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat. Neurosci. 15, 274\u2013283. https:\/\/doi.org\/10.1038\/nn.2997 (2011).","journal-title":"Nat. Neurosci."},{"issue":"Suppl 1","key":"20005_CR41","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/s0387-7604(01)00343-6","volume":"23","author":"M Vacca","year":"2001","unstructured":"Vacca, M. et al. MECP2 gene mutation analysis in the British and Italian Rett syndrome patients: hot spot map of the most recurrent mutations and bioinformatic analysis of a new MECP2 conserved region. Brain Dev. 23 (Suppl 1), 246\u2013250. https:\/\/doi.org\/10.1016\/s0387-7604(01)00343-6 (2001).","journal-title":"Brain Dev."},{"key":"20005_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajmg.a.20571","volume":"126A","author":"C Schanen","year":"2004","unstructured":"Schanen, C. et al. Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. Am. J. Med. Genet. A. 126A, 129\u2013140. https:\/\/doi.org\/10.1002\/ajmg.a.20571 (2004).","journal-title":"Am. J. Med. Genet. A"},{"key":"20005_CR43","doi-asserted-by":"publisher","unstructured":"Mao, Y. et al. Anti-Semaphorin 4D rescues motor, cognitive, and respiratory phenotypes in a Rett syndrome mouse model. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22179465 (2021).","DOI":"10.3390\/ijms22179465"},{"key":"20005_CR44","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1210\/jcem.85.12.7007","volume":"85","author":"AG Moore","year":"2000","unstructured":"Moore, A. G. et al. The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J. Clin. Endocrinol. Metab. 85, 4781\u20134788. https:\/\/doi.org\/10.1210\/jcem.85.12.7007 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"20005_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2144\/02331rr03","volume":"33","author":"DA Brown","year":"2002","unstructured":"Brown, D. A. et al. Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. Biotechniques 33, 118\u2013120. https:\/\/doi.org\/10.2144\/02331rr03 (2002).","journal-title":"Biotechniques"},{"key":"20005_CR46","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1093\/jalm\/jfac055","volume":"7","author":"Y Karusheva","year":"2022","unstructured":"Karusheva, Y. et al. The common H202D variant in GDF-15 does not affect its bioactivity but can significantly interfere with measurement of its circulating levels. J. Appl. Lab. Med. 7, 1388\u20131400. https:\/\/doi.org\/10.1093\/jalm\/jfac055 (2022).","journal-title":"J. Appl. Lab. Med."},{"key":"20005_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf, R. M. Biomarker definitions and their applications. Exp. Biol. Med. (Maywood). 243, 213\u2013221. https:\/\/doi.org\/10.1177\/1535370217750088 (2018).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"20005_CR48","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/neuonc\/nox242","volume":"20","author":"DN Cagney","year":"2018","unstructured":"Cagney, D. N. et al. The FDA NIH biomarkers, endpoints, and other tools (BEST) resource in neuro-oncology. Neuro Oncol. 20, 1162\u20131172. https:\/\/doi.org\/10.1093\/neuonc\/nox242 (2018).","journal-title":"Neuro Oncol."},{"key":"20005_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajmg.b.32707","volume":"180","author":"JL Neul","year":"2019","unstructured":"Neul, J. L. et al. The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2. Am. J. Med. Genet. B Neuropsychiatr. Genet. 180, 55\u201367. https:\/\/doi.org\/10.1002\/ajmg.b.32707 (2019).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"20005_CR50","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.2147\/jir.S523980","volume":"18","author":"K Chen","year":"2025","unstructured":"Chen, K. et al. A multicenter study for Establishing reference intervals of serum GDF-15 levels based on the Chinese population. J. Inflamm. Res. 18, 9495\u20139504. https:\/\/doi.org\/10.2147\/jir.S523980 (2025).","journal-title":"J. Inflamm. Res."},{"key":"20005_CR51","doi-asserted-by":"publisher","unstructured":"Herrmann, J. R. et al. Growth differentiation Factor-15 knockout mice are protected from neonatal Hypoxic-Ischemic injury in a sex-dependent manner. Dev. Neurosci. 1\u201310. https:\/\/doi.org\/10.1159\/000544063 (2025).","DOI":"10.1159\/000544063"},{"key":"20005_CR52","doi-asserted-by":"publisher","unstructured":"Chaffin, A. T. et al. FGF21 controls hepatic lipid metabolism via sex-dependent interorgan crosstalk. JCI Insight. 7 https:\/\/doi.org\/10.1172\/jci.insight.155848 (2022).","DOI":"10.1172\/jci.insight.155848"},{"key":"20005_CR53","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s40618-023-02232-y","volume":"47","author":"V Pena-Leon","year":"2024","unstructured":"Pena-Leon, V. et al. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans. J. Endocrinol. Investig. 47, 1139\u20131154. https:\/\/doi.org\/10.1007\/s40618-023-02232-y (2024).","journal-title":"J. Endocrinol. Investig."},{"key":"20005_CR54","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1152\/japplphysiol.00519.2024","volume":"137","author":"M Arbeau","year":"2024","unstructured":"Arbeau, M. et al. GDF15 associates with, but is not responsible for, exercise-induced increases in corticosterone and indices of lipid utilization in mice. J. Appl. Physiol. (1985). 137, 1512\u20131523. https:\/\/doi.org\/10.1152\/japplphysiol.00519.2024 (2024).","journal-title":"J. Appl. Physiol. (1985)"},{"key":"20005_CR55","doi-asserted-by":"publisher","first-page":"627691","DOI":"10.3389\/fcvm.2021.627691","volume":"8","author":"Y Chee","year":"2021","unstructured":"Chee, Y., Toh, G. L., Lim, C. J., Goh, L. L. & Dalan, R. Sex modifies the association of fibroblast growth factor 21 with subclinical carotid atherosclerosis. Front. Cardiovasc. Med. 8, 627691. https:\/\/doi.org\/10.3389\/fcvm.2021.627691 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"20005_CR56","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1210\/en.2017-00331","volume":"158","author":"KR Larson","year":"2017","unstructured":"Larson, K. R. et al. Sex differences in the hormonal and metabolic response to dietary protein dilution. Endocrinology 158, 3477\u20133487. https:\/\/doi.org\/10.1210\/en.2017-00331 (2017).","journal-title":"Endocrinology"},{"key":"20005_CR57","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/epi4.12534","volume":"6","author":"AK Kwong","year":"2021","unstructured":"Kwong, A. K. et al. High FGF-21 level in a cohort of 22 patients with Dravet Syndrome-possible relationship with the disease outcomes. Epilepsia Open. 6, 685\u2013693. https:\/\/doi.org\/10.1002\/epi4.12534 (2021).","journal-title":"Epilepsia Open."},{"key":"20005_CR58","doi-asserted-by":"publisher","unstructured":"Leng, Y. et al. Valproic acid and other HDAC inhibitors upregulate FGF21 gene expression and promote process elongation in glia by inhibiting HDAC2 and 3. Int. J. Neuropsychopharmacol. 19 https:\/\/doi.org\/10.1093\/ijnp\/pyw035 (2016).","DOI":"10.1093\/ijnp\/pyw035"},{"key":"20005_CR59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/mp.2013.192","volume":"20","author":"Y Leng","year":"2015","unstructured":"Leng, Y. et al. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers. Mol. Psychiatry. 20, 215\u2013223. https:\/\/doi.org\/10.1038\/mp.2013.192 (2015).","journal-title":"Mol. Psychiatry"},{"key":"20005_CR60","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/jnc.15514","volume":"159","author":"J Nomura","year":"2021","unstructured":"Nomura, J., Mardo, M. & Takumi, T. Molecular signatures from multi-omics of autism spectrum disorders and schizophrenia. J. Neurochem. 159, 647\u2013659. https:\/\/doi.org\/10.1111\/jnc.15514 (2021).","journal-title":"J. Neurochem."},{"key":"20005_CR61","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41591-023-02401-9","volume":"29","author":"S Lunke","year":"2023","unstructured":"Lunke, S. et al. Integrated multi-omics for rapid rare disease diagnosis on a National scale. Nat. Med. 29, 1681\u20131691. https:\/\/doi.org\/10.1038\/s41591-023-02401-9 (2023).","journal-title":"Nat. Med."},{"key":"20005_CR62","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1093\/hmg\/ddad069","volume":"32","author":"SSC Amarasekera","year":"2023","unstructured":"Amarasekera, S. S. C. et al. Multi-omics identifies large mitoribosomal subunit instability caused by pathogenic MRPL39 variants as a cause of pediatric onset mitochondrial disease. Hum. Mol. Genet. 32, 2441\u20132454. https:\/\/doi.org\/10.1093\/hmg\/ddad069 (2023).","journal-title":"Hum. Mol. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20005-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20005-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20005-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:59:43Z","timestamp":1760525983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20005-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20005"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20005-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.B. and S.N.B. declare that they receive royalties or licenses from St Vincent\u2019s Hospital for licensed patents. All other authors (A.H., A.A.T., A.D.W., C.E., G.H., and W.G.) declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments were performed in strict accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes (National Health and Medical Research Council) and were approved by the Children\u2019s Medical Research Institute and the Children\u2019s Hospital at Westmead Joint Animal Ethics Committee (Approval Number: 5174.02.21). For human subjects, informed consent was given by families, and ethics approval was provided by the Sydney Children\u2019s Hospitals Network Human Research Ethics Committee (2020\/ETH02699).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"All authors declare that generative artificial intelligence (AI) and AI-assisted technologies have not been utilized in the writing process.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author declarations of AI"}}],"article-number":"36017"}}